Takashi Suzuki, Satoshi Yajima, Akihiko Okamura, Naoya Yoshida, Yusuke Taniyama, Kentaro Murakami, Yu Ohkura, Yasuaki Nakajima, Koichi Yagi, Takashi Fukuda, Ryo Ogawa, Isamu Hoshino, Chikara Kunisaki, Kosuke Narumiya, Yasuhiro Tsubosa, Kazuhiko Yamada, Hideaki Shimada
PURPOSE: This study aimed to determine the clinicopathologic and prognostic significance of squamous cell carcinoma antigen (SCC-Ag) in patients with esophageal SCC who underwent radical surgery without neoadjuvant therapy. METHODS: This study included 566 patients with primary esophageal SCC who underwent radical resection without neoadjuvant therapy at 15 Japanese hospitals between 2008 and 2016. The cutoff value of SCC-Ag was 1.5 ng/mL based on the receiver operating characteristic curves...
2024: Annals of Thoracic and Cardiovascular Surgery